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Thyroid hormones have profound effects onmood and behav-
ior, but the molecular basis of thyroid hormone action in the
adult brain is relatively unknown. In particular, few thyroid
hormone-dependent genes have been identified in the adult
brain despite extensive work carried out on the developing
brain. In this work we performed global analysis of gene ex-
pression in the adult rat striatum in search for genomic
changes taking place after administration of T3 to hypothy-
roid rats. The hormone was administered in two different
schedules: 1) a single, large dose of 25g per 100 g bodyweight
(SD) or 2) 1.5 g per 100 g body weight once daily for 5 d (RD).
Twenty-four hours after the single or last of multiple doses,
gene expression in the striatum was analyzed using Codelink
microarrays. SD caused up-regulation of 149 genes and down-
regulation of 88 genes. RD caused up-regulation of 18 genes
and down-regulation of one gene. The results were confirmed
by hybridization to Affymetrix microarrays and by TaqMan
PCR. Among the genes identified are genes involved in cir-
cadian regulation and the regulation of signaling pathways
in the striatum. These results suggest that thyroid hormone
is involved in regulation of striatal physiology at multiple
control points. In addition, they may explain the beneficial
effects of large doses of thyroid hormone in bipolar disorders.
(Endocrinology 149: 3989–4000, 2008)
THE EFFECTS AND mechanisms of action of thyroidhormone on the developing brain have been exten-
sively studied (1, 2). Thyroid hormone hasmultiple actions
on brain maturation, resulting from regulation of neural
cell migration and differentiation, synaptogenesis, and
myelination. Hypothyroidism alters neuronal migration
in the cerebral cortex and the cerebellum and impairs the
differentiation of pyramidal cells, Purkinje cells, -ami-
nobutyric acid (GABA)ergic cell precursors, oligodendro-
cytes, astrocytes, and microglia. Most if not all of these
actions of thyroid hormone are due to regulation of gene
expression mediated by interaction with transcriptionally
active nuclear receptors (3).
The molecular basis of thyroid hormone action in the ma-
ture brain is less well known, despite its importance in brain
function. In adults thyroid hormone influences mood and
behavior, and thyroid dysfunction very often leads to psy-
chiatric disorders (4). High doses of T4 are effective in bipolar
depression (5, 6). Despite these observations, very little is
known on the mechanisms of action of thyroid hormone in
the adult brain. Neurotransmitter systems are affected by
deficiency or excess of thyroid hormones (7), and thyroid
hormone influences neurogenesis in the subventricular and
subgranular zones in the adult rat brain (8, 9). Thyroid hor-
mone receptors are widely expressed in the adult brain, and
particularly the TR1 isoform has been implicated in the
control of pathways regulating behavior (10). As in other
tissues, it is most likely that the action of thyroid hormone in
the adult brain is exerted through the control of gene ex-
pression. However, an important feature of thyroid hormone
action is that the genes regulated by thyroid hormones in the
developing brain are insensitive to thyroid hormone in the
adult brain, with some exceptions (2).
The purpose of the present work was to fill an important
gap in our knowledge of thyroid hormone action in the adult
brain by the identification of thyroid hormone-responsive
genes. For this study we selected the striatum for two main
reasons. One reason was because the thyroid hormone reg-
ulated gene Nrgn (also known as RC3), is responsive to T3 in
the striatum but not other regions of the adult brain (11).
Another reason was the problems of sensitivity threshold
due to the high complexity of the whole brain: the cellular
complexity of the striatum is not as high as other regions of
potential interest such as the cerebral cortex because a single
cell type, the GABAergic medium-spiny projection neuron,
represents more than 90% of the total cell population. It is
worth mentioning in this context that the striatum was one
of the regions showing altered metabolic activity after ad-
ministration of T4 to bipolar patients (6).
We analyzed the effects of single and multiple doses of T3
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administration to hypothyroid rats on striatal gene expres-
sion by microarray analysis. As a result, we identified novel
gene targets of thyroid hormone. In terms of gene regulation,
the effect of a single, large dose of T3 wasmore dramatic than
that of multiple lower doses, probably indicating that am-
plified gene responses to T3, as occurs in liver (12), are also
present in the adult brain. This observation is important to
explain the beneficial effects of large doses of thyroid hor-
mone in bipolar disorders.
Materials and Methods
Animals and treatment
Rats from the Wistar strain grown in our animal facilities were used.
Protocols for animal handling were approved by the local institutional
Animal Care Committee and followed the rules of the European Union.
Animals were under temperature (22  2 C) and light (12-h light, 12-h
dark cycle; lights on at 0700 h) controlled conditions and had free access
to food and water. Hypothyroidism was induced in adult male rats at
postnatal day (P) 50 by surgical thyroidectomy, taking care to spare the
parathyroid glands (9). To ensure complete thyroidectomy, the ratswere
given the antithyroid compound 2-mercapto-1-methylimidazole (Sigma
Chemical Co., St. Louis, MO) 0.02% in the drinking water until the end
of the experiment, on P75. Hypothyroid rats (referred to as TX) had low
serum levels of both T4 (0.34  0.13 ng/ml) and T3 (0.07  0.05 ng/ml),
compared with normal rats of the same age (24.8  5.7 and 0.49  0.07
ng/ml, respectively). Serum thyroid hormones were measured as de-
scribed (13).
T3 (Sigma), dissolved in 0.05 m NaOH and diluted in saline con-
taining 0.1% BSA, was administered ip to the TX rats according to two
different schedules: in one group T3 was given as a single dose of 25
g of T3 per 100 g body weight on P74, i.e. 24 h before the animals
were killed (SD group). Plasma T3 concentration 24 h after the in-
jection was 4.35  1.93 ng/ml, corresponding to an estimated frac-
tional occupancy of T3 nuclear receptors of 0.87, according to the
formula: occupancy  plasma T3/(plasma T3  0.67) (14). The SD
group was used to identify fast changes of gene expression taking
place after T3 administration to TX rats, under conditions of near full
saturation of nuclear receptors for 24 h. A second group of TX rats
was also treated with T3 but for 5 d with single daily doses of 1.5 g
of T3 per 100 g body weight, starting on P70 (RD group). Plasma T3
concentration 24 h after the last injection was 0.66  0.17 ng/ml and
an estimated T3 receptor occupancy of 0.49. The effect of T3 treatment
was monitored by Northern blotting analysis of liver type 1 deiodi-
nase (D1) mRNA (15) and quantified by densitometry using the
National Institutes of Health Image J software (http://rsb.info.
nih.gov/ij/), with correction for the housekeeping gene Gapdh. Both
treatment schedules resulted in similar inductions of D1 mRNA (TX:
0.40  0.05; SD: 1.30  0.20; RD: 1.15  0.20, P  0.05 for T3 treated
vs. TX).
The animals, weighing about 200 g, were killed by decapitation under
anesthesia with a mixture of ketamine and medetomidine (9) 24 h after
the single T3 dose or the last of themultiple doses. The brain was rapidly
removed and the striatumwas isolated after separation from the internal
capsule and kept frozen at 80 C until RNA preparation.
RNA analysis
Total RNA was isolated individually from each animal using the
Trizol procedure (Invitrogen, Carlsbad, CA), with an additional step of
chloroform extraction. The quality of RNA was analyzed using a Bio-
Analyzer (Agilent, Santa Clara, CA). cDNA was prepared from 250 ng
of RNAusing the high-capacity cDNA reverse transcription kit (Applied
Biosystems, Foster City, CA). For quantitative PCR, a cDNA aliquot
corresponding to 5 ng of the starting RNA was used, with Taqman
Assay-on-Demand primers and the Taqman universal PCR master mix,
No Amp Erase UNG (Applied Biosystems) on a 7900HT fast real-time
PCR system (Applied Biosystems). The PCR program consisted in a hot
start of 95 C for 10 min, followed by 40 cycles of 15 sec at 95 C and 1 min
at 60 C. PCRs were performed in triplicates, using the 18S gene as
internal standard and the 2-cycle threshold method for analysis (16).
Individual striatal RNA samples from six hypothyroid, four SD,
and five RD rats were hybridized to separate Codelink microarrays
(rat whole genome bioarray; GE Healthcare Europe GmbH, Munich, Ger-
many). These arrays contain 33,849 probes, representing 14,519 unique
sequences. A limited survey was also performed using RNA pools from
five animals of each condition and hybridized to the Rat Expression
Array 230A (product 511036 from Affymetrix, Santa Clara, CA), con-
taining 10,417 unique sequences. There were 9749 sequences common to
both platforms (see supplemental Fig. 1, published as supplemental data
on The Endocrine Society’s Journals Online web site at http://endo.
endojournals.org). All procedures were as recommended by the man-
ufacturers. Codelink hybridizations were performed at the Instituto de
Investigaciones Biome´dicas, Madrid, whereas Affymetrix hybridiza-
tions were performed at the University of Pisa.
Analysis of the data from microarray hybridizations
The data were analyzed using the R software (17) and packages from
the Bioconductor project (http://www.bioconductor.org/) (18, 19). The
codelink (20) and affy (21) packages were used for reading and prepro-
cessing the arrays, genefilter (22) for data filtering and limma (23) for
statistical analysis. For Codelink arrays, raw intensities were exported
for each array with the Codelink software and the files read into R.
Background correction using the normexp method and quantile normal-
ization was applied. Probes having a signal to noise ratio (SNR) below
1 in all samples were removed from further analysis. Gene-wise inten-
sities were fitted to a linear model with the experimental group (TX, RD,
and SD) as factor and contrasts RD-TX and SD-TX were computed to
identify genes differentially expressed between the treatments and the
reference group. Genes were selected as differentially expressed with
Padjust  0.05 (24). Data from the Affymetrix arrays were loaded into R
and processed using the robust multichip average (25) method. Genes
were selected based on fold change to compare the results with the
Codelink data. For this task an absolute fold change of 1.6 was used. (0.7
in log2 scale).
We performed an analysis of enriched gene ontology (GO) (26)
categories to look for affected biological processes, molecular func-
tions, or pathways using the PANTHER resource (27). A gene uni-
verse was created by filtering from the list of all probes in the array
those not expressed, i.e. with a SNR less than 1 in all samples. After
that, we translated the probe identifiers to Entrez Gene identifiers
(removing any probe without Entrez Gene) and filtered those lacking
GO annotations. Finally, we removed all duplicated Entrez Gene
identifications, obtaining 7,287 identifiers from the original 33,849
probes (supplemental Table 1. For the test we translated the list of
differentially expressed genes to Entrez Gene and removed those not
present in the universe.
FIG. 1. Effects of T3 on gene expression in the adult rat striatum. A, Two-dimensional representation of expression values (heat map) across
all samples and differentially expressed genes. All intensities were normalized across the rows (subtracting the mean and dividing by the SD)
to enable comparison between genes. The normalized log intensity values of the probes were centered to the median value of each probe set
and colored on a range of2 (red) and2 (blue); yellow indicates intermediate value. Columns correspond to samples, whereas row corresponds
to individual probe sets (in some cases several probe sets correspond to the same gene). Two main clusters, a and b, classify the differentially
expressed genes as having higher or lower expression after T3 treatment, respectively. The horizontal arrow shows a cluster of genes showing
higher expression after multiple doses of T3 (RD group) but not after a single dose (SD group). B, The profiles plot shown here contains the
same information found in the heatmap butwith a different perspective. This allows us to focus on the general tendency of selected gene clusters.
Signal intensities are normalized as in the heat map and expression values and colored based on the overall pattern. For each pattern, a loess
(locally weighted polynomial regression) fit line describes the overall profile of the corresponding group. This tendency profile is plotted
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SD candidate genes
RD candidate genes
A B
a
b
separately for genes up-regulated (red and green) and down-regulated (blue). The upper panel shows the expression values of each of the 222
up-regulated sequences and 112 down-regulated sequences selected after the T3 single dose (SD group) in the individual arrays for the three
experimental groups. The lower panel corresponds to the expression values of each of the 25 up-regulated sequences and the one that was
down-regulated after the T3 repeated dose (RD group). In the RD group, the up-regulated genes follow two trends: one with little change in
the SD group (green line) and another that was also changed in the SD group (red line); there was only one gene decreased after RD (blue line).
Most of the genes in cluster a of the heat map correspond to genes following the blue line in B. On the other hand, genes in cluster b in the
heat map correspond to genes following the red line in B. Those genes indicated with the green line correspond to the cluster shown with an
arrow in the heat map.
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Results
Effects of T3 on gene expression in the adult striatum
To analyze the effects of thyroid hormone on gene expres-
sion in the adult rat striatum, T3 was administered to hypo-
thyroid rats either acutely (SD) or as single daily doses (RD).
RNA from individual rat striata was used to hybridize
Codelink microarrays. Both the SD and RD treatments re-
sulted in changes of gene expression. Figure 1A shows the
hierarchical clustering (heat map) of all the individual data
representing the differentially expressed sequences at a sig-
nificance level of Padjust 0.05. The complete, annotated heat
map is shown as supplemental Fig. 2. The columns contain
the data from individual samples, which clustered in three
groups as a function of treatment. The rows show the relative
intensity of the probes, centered around the mean intensity
for all individual RNAs. The probes were grouped in two
main clusters: one group (cluster a) contained sequences
whose expression increased after T3. The second group (clus-
ter b) contained sequences whose expression was decreased
by T3. Visual inspection of the heatmap also revealed that the
effect of the SDwasmore pronounced than the RD, although
in most cases there was also an effect but of lower intensity
of the RD.
The comparisons between the effects of the SD vs. the RD
are clearly seen in the plot profiles shown in Fig. 1B. These
plots show the expression values along different arrays for
the probes selected as differentially expressed in the two
treatment groups. The signal intensities are scaled to the
same range so that they can be compared. The tendency
profile [Loess curve (28)] is plotted separately for up-regu-
lated (Fig. 1B, red and green) and down-regulated (Fig. 1B,
blue) genes. The upper panel shows the behavior in each group
of the genes that changed after the single T3 dose (SD group).
The lower panel shows the genes whose expression was
changed after the multiple T3 doses (RD group). The data
indicate that administration of a single high dose of T3 sets
in motion large changes of gene expression, in contrast to the
more discrete changes after treatment with the much lower,
multiple doses.
Figure 2 shows the MA scatter plots (Fig. 2, upper panels)
and the Venn diagram (Fig. 2, lower panel). The MA plots
relate the log2 of the fold change (M) of the signal after T3
DRDSA
down-regulated
up-regulated
B
FIG. 2. Effects of single (SD) and multiple (RD) doses of T3 on gene expression after administration to TX animals. A, MA plots, relating the
log2 of the fold change (M, in ordinate) vs. the mean of log intensity of the signal (A, in abscissa) of SD vs. TX and RD vs. TX. Red and orange
dots represent probe sets having SNRs of 1 or below. Black dots are probe sets with SNR above 1. The blue dots represent the differentially
expressed sequences, with Padjust  0.05. B, Venn diagram showing the quantitative relation between the number of sequences differentially
expressed in the SD and RD groups.
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treatment with its mean log-expression level (A) in the
treated and untreated groups. The dotted horizontal lines rep-
resent a fold change of 2 for up-regulated genes or 50% for
down-regulated genes. The blue dots represent the differen-
tially expressed probe sets with Padjust  0.05. In the SD
group, 334 sequences were differentially expressed with re-
spect to the hypothyroid animals. From them, 222 sequences
were up-regulated and 112 sequences down-regulated. After
subtracting 80 nonannotated sequences and 17 repeated
probes, there were 149 up-regulated and 88 down-regulated
genes. Many of the statistically significant, differentially ex-
pressed genes had absoluteMvalues as low as 0.5, indicating
moderate changes of gene expression. After filtering the data
on the basis of fold change, there were 91 up-regulated genes
and 53 down-regulated geneswith absoluteMvalues greater
than 0.7.
The RD caused changes of expression of 26 sequences.
After subtracting the nonannotated and repeated sequences,
18 genes were up-regulated and one was down-regulated
[Gja7, or connexin 45 (29)]. As shown in the intersection
between the SD and RD in the Venn diagram, 17 sequences
were up-regulated with both treatment schedules. This set of
17 sequences corresponded to 10 unique genes: the canna-
binoid receptor Cnr1, an important G protein-coupled re-
ceptor (30), recently linked to hyperactivity of neonatal hy-
pothyroid rats (31); angiotensin converting enzyme, Ace, a
component of brain renin-angiotensin system (32); the sonic
hedgehog transcriptional effector Gli1, linked to neuropro-
tection in the adult brain (33); the sonic hedgehog responsive
gene Ith3 [inter- trypsin inhibitor (34)]; the extraneuronal
monoamine transporter Slc22a3, implicated in several neu-
rological disorders (35); the voltage gated sodium channel
4-subunit, Scn4b, involved in electrical signaling and cell
adhesion and defective in Huntington’s disease (36, 37); the
small heat shockproteinHspb6 (38);Grifin, or galactin-related
interfiber protein originally described in the lens (39); and
Loc290651, similar to myoinositol 1-phosphate synthase A1,
and RGD1305038_predicted, similar to serum-inducible
kinase.
The mean expression of the eight sequences specifically
increased by RD with P  0.05 is represented as a green line
in the plot profile of Fig. 1B. Seven of these sequences could
be observed as a prominent cluster in the heat map (Fig. 1,
horizontal arrow). Three of these genes are related to red blood
cells (Loc287167, Hba1, and AlaS2); Ceacam1 encodes a cell
adhesion molecule (40); Prph1 encodes the intermediate fil-
ament and Akt substrate peripherin (41, 42); and Cd52 en-
codes a surface antigen.
The complete set of genes that were differentially ex-
pressed in the SD and RD groups, selected on the basis of
statistical significance is shown as supplemental Table 2.
From these data, genes having a fold change of at least 1.6 in
any of the two treatment groups are displayed in Table 1.
This table shows the fold change in the SD and the RDgroups
and the A value. The A value corresponds to the mean of the
log2 intensity values over all samples and is a measure of the
average expression level. Values with Padjust 0.05 are high-
lighted. The genes were categorized according to the bio-
logical processes or molecular function assigned by GO
annotation (26). The GO annotation suggested that the dif-
ferentially expressed genes were involved in a variety of
biological processes.
To determine the statistical significance of these observa-
tions, we used PANTHER analysis to identify those catego-
ries significantly over- or downrepresentedwithin the group
of differentially expressed genes in relation to the universe
of expressed genes in the striatum as found in the arrays
(7287; seeMaterials andMethods). The analysis (supplemental
Table 3) showed the pathway, biological process and mo-
lecular function categories with over- or downrepresented
candidate genes with P 0.05.Within the pathway category,
we found three genes related to the circadian clock system
(Per1, Per2, Nr1d2); heterotrimeric G protein signaling
pathways (Gq and Go-mediated pathways: Rgs2, Rgs14,
Rgs9, Rasgrp1, Arhgef3_predicted, Rhoc_predicted, Rap1ga1,
Rasgrp2_predicted); oxidative stress response (Dusp1,
Dusp5, Map2k3, Dupd1_predicted); phenylethylamine deg-
radation (Aldh1a1, Doxl1); and MAPK pathway (Map2k3,
Fos, Rps6ka4_predicted). Within the biological process and
molecular function categories, we found, among others,
genes involved in regulation of phosphate metabolism,
signal transduction, tyrosine kinase signaling pathways,
extracellular transport and import, cell structure, and neu-
ronal activity.
Confirmation of microarray data
We used two approaches to confirm the data. First, we
checked the reproducibility of the assay in a different plat-
form. Reproducibility of microarray data across different
platforms and laboratories is dramatically dependent on the
criteria used to select the differentially expressed genes (43).
In our studies we analyzed individual RNAs and applied the
limma statistics to account for variability of the data and
therefore selected the candidate genes on the basis of ad-
justed P value. On the other hand, it has been noted that
selection on the basis on fold change achieves better repro-
ducibility among different platforms and biological groups
than a selection based on t statistics (44, 45).
Therefore, as a secondary screening for partial validation
of the data and to select sequences for further confirmation
by PCR, we performed an independent analysis using the
Affymetrix platform. In this assay, we used pools of RNA
instead of individual samples. Striatal RNA from five ani-
mals of each group were pooled and hybridized to the Af-
fymetrix rat expression arrays 230A. Candidate genes were
selected on the basis of an increase or decrease of at least
1.6-fold and compared with the candidate genes previously
selected from the Codelink arrays. These comparisons were
limited by the fact that some genes were uniquely present in
one of the two different arrays (see supplemental Fig. 1 and
supplemental Table 4). Fifty two differentially expressed
genes from the Codelink platform were absent from the
Affymetrix arrays, and 20 genes with an M value above 0.7
in the Affymetrix arrays were absent from the Codelink
arrays. Among the latter, Nrgn and Tubb3, known to be
dependent of the thyroid status (11, 46), were found as in-
duced by SD andRD treatments in theAffymetrix arrays (not
shown) but were not present as probes in the Codelink
arrays.
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TABLE 1. Differentially expressed genes grouped by biological process (BP; GO)
Entrezid Symbol Name SD RD A
BP: regulation of transcription, DNA dependent
140589 Gli1 GLI-Kruppel family member GLI1 3.43 2.35 4.45
306873 Rreb1_predicted Ras responsive element binding protein 1 (predicted) 2.91 1.13 5.62
24309 Dbp D site albumin promoter binding protein 2.66 1.07 5.91
60563 hr Hairless homolog (mouse) 2.64 1.00 6.02
298894 Mycn V-myc myelocytomatosis viral related oncogene, neuroblastoma derived
(avian) (mapped)
2.30 1.17 5.44
313575 Heyl_predicted Hairy/enhancer-of-split related with YRPW motif-like (predicted) 2.23 1.49 4.89
24309 Dbp D site albumin promoter binding protein 2.00 1.13 9.47
361715 Rps6ka4_predicted Ribosomal protein S6 kinase, polypeptide 4 (predicted) 1.93 1.25 5.91
117560 Klf9 Kruppel-like factor 9 1.91 1.55 8.67
117560 Klf9 Kruppel-like factor 9 1.83 1.48 10.58
308435 Cic_predicted Capicua homolog (Drosophila) (predicted) 1.67 1.20 8.21
497984 RGD1566329 predicted Similar to zinc finger protein 652 (predicted) 1.13 6.73 5.13
287422 Per1 Period homolog 1 (Drosophila) 1.83 1.23 6.61
24330 Egr1 Early growth response 1 1.99 1.02 10.5
25129 Egr4 Early growth response 4 2.16 1.13 8.31
114519 Nfil3 Nuclear factor, IL-3 regulated 2.27 1.06 6.01
304741 Tcfcp2l1_predicted Transcription factor CP2-like 1 (predicted) 2.35 1.13 2.81
314322 Fos FBJ murine osteosarcoma viral oncogene homolog 3.07 1.16 7.66
79240 Nr4a1 Nuclear receptor subfamily 4, group A, member 1 3.71 1.16 8.46
58853 Nr4a3 Nuclear receptor subfamily 4, group A, member 3 3.81 1.12 5.57
58853 Nr4a3 Nuclear receptor subfamily 4, group A, member 3 4.29 1.03 7.26
114090 Egr2 Early growth response 2 4.96 1.07 6.51
29546 Homer1 Homer homolog 1 (Drosophila) 5.58 1.30 6.64
BP: intracellular signaling cascade
64032 Ctgf Connective tissue growth factor 2.99 1.64 5.3
60669 Cmklr1 Chemokine-like receptor 1 2.31 1.22 5.81
25248 Cnr1 Cannabinoid receptor 1 (brain) 2.11 2.03 8.55
361715 Rps6ka4_predicted Ribosomal protein S6 kinase, polypeptide 4 (predicted) 1.93 1.25 5.91
311118 Tlk1_predicted Tousled-like kinase 1 (predicted) 1.64 1.11 4.91
114108 Pdlim3 PDZ and LIM domain 3 1.80 1.11 6.89
24716 Ret Ret protooncogene 1.87 1.60 4.12
29546 Homer1 Homer homolog 1 (Drosophila) 5.58 1.30 6.64
Small GTPase-mediated signal transduction
306873 Rreb1_predicted Ras responsive element binding protein 1 (predicted) 2.91 1.13 5.62
310838 Bcar3_predicted Breast cancer antiestrogen resistance 3 (predicted) 2.57 1.39 6.61
310838 Bcar3_predicted Breast cancer antiestrogen resistance 3 (predicted) 2.39 1.33 6.61
114203 Aps Adaptor protein with pleckstrin homology and src homology 2 domains 2.31 1.12 5.39
303653 Cdc42ep4_predicted CDC42 effector protein ( GTPase binding) 4 (predicted) 2.25 1.19 6.77
303653 Cdc42ep4_predicted CDC42 effector protein ( GTPase binding) 4 (predicted) 2.23 1.29 6.84
171099 Rasd2 RASD family, member 2 1.88 1.45 10.03
299824 RGD1305255 predicted Similar to CG3996-PA (predicted) 1.79 1.53 5.61
360571 Rab34 RAB34, member of RAS oncogene family 1.67 1.15 6.57
192126 Dab2ip Disabled homolog 2 (Drosophila) interacting protein 1.65 1.15 8.78
292750 Plekhg2_predicted Pleckstrin homology domain containing, family G (with RhoGef domain)
member 2 (predicted)
1.66 1.04 6.63
308821 Rab30 RAB30, member RAS oncogene family 2.81 1.24 3.71
686142 LOC686142 Similar to Ral guanine nucleotide dissociation stimulator (RalGEF)
(RalGDS)
2.85 1.13 6.01
G protein-coupled receptor protein signaling pathway
29481 Rgs9 Regulator of G-protein signaling 9 2.75 1.62 5.26
29481 Rgs9 Regulator of G-protein signaling 9 2.71 1.78 6.01
84583 Rgs2 Regulator of G-protein signaling 2 1.66 1.09 8.9
Protein tyrosine phosphatase activity
246781 Ptpn7 Protein tyrosine phosphatase, nonreceptor type 7 1.64 1.04 6.65
171109 Dusp5 Dual specificity phosphatase 5 2.03 1.06 5.02
295338 Ptpn22_predicted Protein tyrosine phosphatase, nonreceptor type 22 (lymphoid) (predicted) 1.65 1.05 4.73
114856 Dusp1 Dual-specificity phosphatase 1 2.06 1.39 7.01
BP: rhythmic process
24309 Dbp D site albumin promoter binding protein 2.66 1.07 5.91
24309 Dbp D site albumin promoter binding protein 2.00 1.13 9.47
287422 Per1 Period homolog 1 (Drosophila) 1.83 1.23 6.61
29461 Vgf VGF nerve growth factor inducible 1.95 1.08 9.05
114090 Egr2 Early growth response 2 4.96 1.07 6.51
BP: cation transport
29504 Slc22a3 Solute carrier family 22, member 3 2.73 2.35 5.26
83500 Slc22a8 Solute carrier family 22 (organic anion transporter), member 8 2.69 1.72 4.28
(Continues)
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TABLE 1. Cont.
Entrezid Symbol Name SD RD A
29726 Slc22a5 Solute carrier family 22 (organic cation transporter), member 5 2.16 1.02 4.96
315611 Scn4b Sodium channel, voltage-gated, type IV,  1.97 1.56 10.65
315611 Scn4b Sodium channel, voltage-gated, type IV,  1.88 1.65 9.67
170546 Ryr3 Ryanodine receptor 3 1.84 1.09 7.56
170546 Ryr3 Ryanodine receptor 3 1.83 1.19 6.38
252919 Slc38a3 Solute carrier family 38, member 3 1.82 1.13 5.33
170924 Abcc4 ATP-binding cassette, subfamily C (CFTR/MRP), member 4 1.67 1.15 4.91
155205 Slc36a1 Solute carrier family 36 (proton/amino acid symporter) member 1 2.16 1.01 3.73
85267 Slc24a3 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 2.41 1.00 3.29
BP: cell organization and biogenesis
315131 Kdelr3_predicted KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention
receptor 3 (predicted)
6.50 1.52 3.01
63878 Stc2 Stanniocalcin 2 5.54 3.41 2.73
25602 Tnxa Tenascin XA 5.21 1.93 5.97
316638 Sned1 Insulin responsive sequence D binding protein-1 2.93 1.67 5.76
362650 Fblim1 Filamin binding LIM protein 1 2.81 1.96 3.45
171112 Wfdc1 WAP four-disulfide core domain 1 2.17 1.27 7.69
29317 Csrp2 Cysteine and glycine-rich protein 2 2.04 1.40 7.16
89806 Tie1 Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 1.91 1.14 6.48
307235 RGD1311910 predicted Similar to hypothetical p38 protein (predicted) 1.88 1.08 6.52
85251 Col18a1 Procollagen, type XVIII, 1 1.80 1.13 4.39
308345 Suv420h2_predicted Suppressor of variegation 4–20 homolog 2 (Drosophila) (predicted) 1.68 1.22 7.43
360537 Tom1l2_predicted Target of myb1-like 2 (chicken) (predicted) 1.68 1.01 4.85
362584 Col9a2_predicted Procollagen, type IX, 2 (predicted) 1.68 1.13 5.94
81613 Ceacam1 CEA-related cell adhesion molecule 1 1.46 2.53 4.71
266706 Gja7 Gap junction membrane channel protein 7 1.09 1.78 4.11
24688 Prph1 Peripherin 1 1.10 1.92 8.11
362873 Plxnc1_predicted Plexin C1 (predicted) 1.62 1.16 5.11
287925 Pkp2 Plakophilin 2 1.62 1.05 5.61
306081 Pcdh20_predicted Protocadherin 20 (predicted) 1.65 1.03 7.27
54323 Arc Activity regulated cytoskeletal-associated protein 2.00 1.15 7.86
306548 Hook3 Hook homolog 3 (Drosophila) 2.01 1.18 2.86
79110 Mepe Matrix extracellular phosphoglycoprotein with ASARM motif (bone) 2.58 1.11 2.99
BP: cellular lipid metabolism
89826 Rpe65 Retinal pigment epithelium 65 3.23 1.61 3.36
89826 Rpe65 Retinal pigment epithelium 65 2.16 1.71 4.08
84575 Fads1 Fatty acid desaturase 1 1.93 1.47 6.81
117243 Acsl6 Acyl-CoA synthetase long-chain family member 6 1.82 1.36 8.95
94338 Smpd3 Sphingomyelin phosphodiesterase 3, neutral 1.77 1.28 8.76
170465 Acaa2 Acetyl-coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-coenzyme
A thiolase)
1.67 1.09 7.39
25702 Pnlip Pancreatic lipase 1.46 1.91 7.32
304741 Tcfcp2l1_predicted Transcription factor CP2-like 1 (predicted) 2.35 1.13 2.81
BP: protein metabolism
24310 Ace Angiotensin I-converting enzyme (peptidyl-dipeptidase A) 1 4.66 2.79 6.87
295394 Dph5 DPH5 homolog (S. cerevisiae) 2.20 1.35 2.84
25697 Ctsl Cathepsin L 1.72 1.21 5.91
364948 Asphd2 Aspartate -hydroxylase domain containing 2 1.69 1.25 7.67
308345 Suv420h2_predicted Suppressor of variegation 4–20 homolog 2 (Drosophila) (predicted) 1.68 1.22 7.43
300981 Acy1 Aminoacylase 1 1.67 1.28 7.66
310467 Tiparp_predicted TCDD-inducible poly(ADP-ribose) polymerase (predicted) 1.85 1.16 5.91
303287 Fbxo39 F-box protein 39 2.27 1.20 4.26
29154 Capn2 Calpain 2 2.39 1.11 6.91
BP: others
303772 Slc16a6 Solute carrier family 16 (monocarboxylic acid transporters), member 6 5.78 2.11 6.89
303772 Slc16a6 Solute carrier family 16 (monocarboxylic acid transporters), member 6 4.86 2.25 4.37
303772 Slc16a6 Solute carrier family 16 (monocarboxylic acid transporters), member 6 4.29 1.21 2.89
293628 RGD1308955 Similar to Cc1–9 3.81 2.04 3.31
314627 RGD1305038 predicted Similar to serine/threonine-protein kinase SNK (serum inducible kinase)
(predicted)
3.25 1.71 6.62
296048 Agpat7_predicted 1-Acylglycerol-3-phosphate O-acyltransferase 7 (lysophosphatidic acid
acyltransferase, ) (predicted)
2.51 1.71 7.01
192245 Hspb6 Heat shock protein, -crystaline-related, B6 2.22 1.60 7.72
50693 Itih3 Inter- trypsin inhibitor, heavy chain 3 1.95 2.53 8.61
287437 Tnfsf13 TNF (ligand) superfamily, member 13 1.91 1.17 6.31
303601 Cyb561_predicted Cytochrome b-561 (predicted) 1.88 1.39 8.2
54283 Pfkfb4 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 1.83 1.12 6.11
24188 Aldh1a1 Aldehyde dehydrogenase family 1, member A1 1.67 1.55 5.33
(Continues)
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Entrezid Symbol Name SD RD A
260327 Fndc5 Fibronectin type III domain containing 5 1.67 1.29 7.93
293587 RGD1311186 predicted Similar to RIKEN cD 1810014F10 gene (predicted) 1.66 1.30 7.16
303242 DLP2 Dynein-like protein 2 1.62 1.13 6.11
25748 Alas2 Aminolevulinic acid synthase 2 1.12 5.06 4.27
287167 LOC287167 Globin,  1.04 11.39 7.22
25632 Hba-a1 Hemoglobin-, adult chain 1 1.39 7.46 4.46
304017 Tomm70a Translocase of outer mitochondrial membrane 70 homolog A (yeast) 1.66 1.02 10.4
25741 Pfkl Phosphofructokinase, liver, B-type 1.97 1.02 5.91
171128 Gchfr GTP cyclohydrolase I feedback regulator 2.46 1.75 3.93
292686 Fbxo46 F-box protein 46 2.77 1.25 5.67
29625 Crhbp Corticotropin releasing hormone binding protein 3.16 1.22 5.21
MF: others
301073 Gup1_predicted Gup1, glycerol uptake/transporter homolog (yeast) (predicted) 4.63 1.71 5.73
309208 RGD1564983 predicted Similar to leucine rich repeat containing 10 (predicted) 3.86 2.00 8.01
500590 LOC500590 Similar to T cell antigen 4–1BB precursor-mouse 3.56 1.16 4.73
117130 Grifin Galectin-related interfiber protein 2.41 5.31 3.27
363931 Gtpbp6_predicted GTP binding protein 6 (putative) (predicted) 2.19 1.26 9.32
288689 RGD1566317 predicted Similar to tescalcin (predicted) 2.04 1.44 9.13
63886 Abcb9 ATP-binding cassette, subfamily B (MDR/TAP), member 9 1.93 1.45 6.77
367747 RGD1564763 predicted Similar to nudix (nucleoside diphosphate linked moiety X)-type motif 11
(predicted)
1.85 1.38 5.85
361348 RGD1559803 predicted Similar to maestro (predicted) 1.73 1.27 6.59
171451 Mosc2 MOCO sulphurase C-terminal domain containing 2 1.69 1.07 8.92
362597 RGD1308876 predicted Similar to 2610027C15Rik protein (predicted) 1.67 1.07 5.11
361552 Wtip_predicted WT1-interacting protein (predicted) 1.65 1.04 6.57
89789 Lbr Lamin B receptor 1.64 1.15 4.65
306860 Gcnt2 Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme 1.69 1.05 7.28
64629 Porf1 Preoptic regulatory factor 1 1.85 1.65 7.41
312316 Doxl1 Diamine oxidase-like protein 1 2.53 1.22 4.48
366624 Cfl2_predicted Cofilin 2, muscle (predicted) 2.83 1.13 2.71
360949 Cpeb2_predicted Cytoplasmic polyadenylation element binding protein 2 (predicted) 3.61 1.04 4.48
No data
307494 RGD1305640 predicted Similar to RIKEN cD 2410080P20 (predicted) 2.79 1.80 3.61
289235 Slamf9_predicted SLAM family member 9 (predicted) 2.68 1.41 4.31
308794 RGD1310371 Similar to RIKEN cD 1700026D08 2.60 1.66 6.11
300317 RGD1311154 predicted Similar to hypothetical protein FLJ12242 (predicted) 2.35 1.49 9.42
361267 Akr1cl1_predicted Aldo-keto reductase family 1, member C-like 1 (predicted) 2.33 1.27 4.69
361853 RGD1311294 predicted Similar to hypothetical protein C6orf60 (predicted) 2.30 1.48 5.59
691504 LOC691504 Similar to Zinc finger protein ZFPM1 (Zinc finger protein multitype 1)
(friend of GATA protein 1) (friend of GATA-1) (FOG-1)
2.27 1.33 6.99
500200 RGD1561512 predicted Similar to bHLH factor Math6 (predicted) 2.25 1.49 3.89
313837 RGD1562284 predicted Similar to glutaminyl-peptide cyclotransferase precursor (QC)
(predicted)
2.13 1.67 6.75
499745 LOC499745 Similar to Notch-regulated ankyrin repeat protein 1.96 1.20 4.64
266764 Tbkbp1 TBK1 binding protein 1 1.89 1.42 6.62
361519 RGD1564862 predicted Similar to hypothetical protein MGC51082 (predicted) 1.84 1.27 8.61
303671 Fads6_predicted Fatty acid desaturase domain family, member 6 (predicted) 1.72 1.18 7.71
362246 Trp53inp2 Tumor protein p53 inducible nuclear protein 2 1.68 1.39 9.41
500059 RGD1559885 predicted Similar to hypothetical gene supported by BC063892 (predicted) 1.65 1.09 6.93
117054 Cd52 CD52 antigen 1.59 6.54 2.76
691478 LOC691478 Similar to copine-6 (copine VI) (Neuronal-copine) (N-copine) 1.71 1.39 8.28
305549 Peli1 Pellino homolog 1 (Drosophila) 1.71 1.00 7.21
499839 RGD1564664 predicted Similar to LOC387763 protein (predicted) 1.73 1.17 9.48
494538 LOC494538 ABP 1.78 1.24 5.12
691164 LOC691164 Similar to pellino homolog 1 (Drosophila) 1.92 1.04 7.27
363496 Armcx6 Armadillo repeat containing, X-linked 6 1.96 1.13 6.91
500204 RGD1562515 predicted Similar to RIKEN cD 4931417E11 (predicted) 1.97 1.32 4.32
361003 Dupd1_predicted Dualspecificity phosphatase and proisomerase domain containing 1
(predicted)
2.28 1.01 2.91
298605 RGD1566169 predicted Similar to hypothetical protein MGC37938 (predicted) 2.50 1.60 5.62
Shown are the genes with a fold change above 1.6 or below1.6, in any of the SD or RD groups. Fold changes are represented in natural
scale, computing the magnitude with the most abundant transcript in the numerator. The sign indicates the direction of the change:
positive values refer to greater transcript abundance in RD or SD respect to the reference (TX), whereas negative values indicate less
abundance. Shown also is the A value: mean of the log2 intensity values over all samples as a measure of the average expression level.
The genes are grouped by the BP categories of GO. Repeated probes were not omitted. In bold, the fold change of probes with Padjust 
0.05. MF, Molecular functions.
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From the genes common to both platforms (supplemental
Table 5), five were up-regulated by both T3 treatment sched-
ules (see below), and threewere up-regulated by the RD only
(Hba1, Alas2, Loc287167). From the SD treatments, 26 up-
regulated and 14 down-regulated genes were confirmed in
both platforms. Among the SD up-regulated genes, hr (or
hairless), Rasd2 (also known as Rhes), and Klf9 (also known
as BTEB) are already known to be thyroid hormone-regu-
lated genes. Among the SD down-regulated genes, there
were several early response genes (Egr1, Arc, Dusp1, Egr4,
Fos, Nr4a1, Nr4a3, Egr2, and Homer1).
For biological confirmation using Taqman PCR, we used
a different group of rats from the ones used for the arrays.
The genes selected for confirmation included the five genes
thatwere up-regulated by both SD andRD in both platforms:
Ace (angiotensin converting enzyme),Hspb6 (heat shock pro-
tein B6), Cnr1 (cannabinoid receptor 1), Itih3 (inter- trypsin
inhibitor), and Scn4b (voltage-gated sodium channel IV). We
also checked Rgs9 (regulator of G protein signaling 9), a
striatum-specific gene (47), which shows a robust increase by
SD; Klf9 (Kruppel-like factor, also known as basic transcrip-
tion factor binding protein, or BTEB), a gene previously
shown to be regulated by thyroid hormone in several cell
types (48);Dbp (D-site binding protein); Rasgrp1 (also known
as CalDAG-GEF1); and the early response genes Nr4a1(also
known as NGFIB), Arc, Dusp1, Egr1 (also known as NGFIA),
andHomer1. The results, shown in Fig. 3, show that therewas
a good correlation between the results from the arrays and
the PCR, both in the direction and magnitude of expression
changes.
Discussion
In this article we provide, for the first time, a comprehen-
sive list of genes that are differentially expressed by thyroid
hormone in the adult striatum. Our approach involved the
analysis of gene expression after administration of T3 to
hypothyroid rats.
Most previous studies on the effects of T3 on brain gene
expression have been limited to the postnatal period, and few
genes were known to be sensitive to T3 in the adult brain. In
one study, Haas et al. (49) used a limited set of 1224 neural-
specific genes and found that hyperthyroidism induced only
modest changes in the expression of 11 genes. This study is
not comparable with ours, first because of the limited num-
ber of genes in the array, second because total brain was
analyzed, and third because T3 was given at doses 10-fold
higher than in this work and for 10 consecutive days so that
the animals were hyperthyroid.
One of the earliest genes identified as regulated by T3 in
the adult brain is Nrgn, a gene confirmed to be regulated at
the transcriptional level in cultured neurons (50) and dem-
onstrated to be a sensitive marker of T3 action. Nrgnwas not
recovered initially in the list of candidate genes because it
was not present as a hybridizable probe in the arrays. How-
ever, it was present in the Affymetrix chips andwas detected
after the acute and multiple-dose treatments, in agreement
with previous studies. Other genes present as candidate
genes and previously shown to be regulated by thyroid hor-
mones in other paradigms include Klf9 (48), Egr1 (51), the
mitochondrial importer Tomm70 (52), the transcription factor
Hr (53), the small G protein Rasd2 (also known as Rhes) (54),
the transcription factor Nr4a1 (55), the cannabinoid receptor
Cnr1 (31), and the dual-specificity phosphatase Dusp1 (56).
Early studies byOppenheimer and colleagues (57) showed
that the response of some genes, such as pituitary GH, fol-
lowed a linear response in relation to nuclear occupancy after
T3 administration. Expression of these genes did not increase
above the baseline euthyroid level. For other genes, exem-
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FIG. 3. Correlation between data from Codelink and
Affymetrix hybridizations and Taqman PCR assays of
selected differentially expressed genes from the SD and
RD groups.
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plified by liver enzymes, the response was nonlinear and
amplifiedwith further increases of receptor occupancy above
the euthyroid level of about 50% (12).
Based on these studies, the dosage and timing of T3 ad-
ministrationwas chosen by us so that twodifferent situations
were reached. The single dose was intended to result in near
full saturation of nuclear receptors for 24 h. Twenty-four
hours after injection, the fractional occupancy of nuclear
receptors was calculated to be 0.86. In the case of multiple
injections, the fractional occupancy 24 h after the last injec-
tion was 0.49, which is the physiological occupancy of T3
receptors in liver (12). The single injection protocol should
likely select for fast, linear, and amplified responses after T3,
whereas the multiple injection dosage should identify linear,
steady-state responses. Therefore, it is not surprising that the
number of candidate genes was larger after the acute injec-
tion of T3 than after themultiple daily doses. In theRDgroup,
there were one down-regulated gene and eight up-regulated
genes. The only down-regulated gene, Gja7, encodes a gap
junction membrane channel protein expressed in several re-
gions of the central nervous system but not in the striatum
(58). This agrees with the almost no expression found in the
RD-treated rats, indicating that thyroid hormone is involved
in maintaining Gja7 repression under normal conditions.
Three of the up-regulated geneswere of red blood cell origin.
The significance of this finding is uncertain. Interestingly,
Hba1 has also been found previously to be regulated by T3
in the cerebellum in vivo and in primary cultures of cerebellar
granular cells, presumably at the transcriptional level (56).
The functional significance of the regulation of the rest of
genes comprising this small set of candidate genes is un-
certain because they do not share common functional
properties.
Despite the above, the expression of many genes after the
RD falls between the levels of the hypothyroid and acutely
treated rats, indicating that the group of genes sensitive to
each of the treatment schedules is qualitatively similar. Ac-
tually, we calculate that 52% of the differentially expressed
genes in the SD were changed in the RD by at least 20%, and
in the same direction. This justifies the functional analysis
performed using the PANTHER resource from the list of all
candidate genes found under the two treatment schedules.
On the other hand, the overlap between the SD and RD
suggests that the genes induced in both treatment schedules
are regulated at the transcriptional level.
PANTHER analysis of the significance of represented
pathways disclosed three genes of the circadian clock system.
Although not present in the PANTHER analysis, another
regulated gene, Dbp, has been described as a circadian gene
(59). Also, other genes related to the wakefulness (Fos, Arc,
Hsps, Egr1, Homer) (59) were sensitive to T3. Because at least
one of these genes, Dbp, has been proposed as a candidate
gene in bipolar disorders (60), it is tempting to speculate that
the beneficial effects of large doses of thyroid hormones in
bipolar disorders is mediated, at least in part, through reg-
ulation of the expression of these genes.
Another group of candidate genes have important roles in
the physiology of striatal neurons. There are 314 genes of
enriched expression in the striatum (61), fromwhich 21 were
differentially expressed after T3 treatment (supplemental Ta-
ble 6). Some of these genes are defective in Huntington’s
disease (37), such as Scn4b,Rasd2,Rasgrp1,Klf9, and Rgs9. The
latter is also one of the 10most enriched genes in the striatum
in relation to other brain regions (61). Central to striatal
neuron signaling is the regulation of dopamine and cAMP-
regulated phosphoprotein (DARPP)-32 phosphorylation
[Fig 4 (62)]. Phospho-DARPP-32 levels are controlled by the
cAMP-protein kinase A pathway, which promotes phos-
phorylation, and by the Ca2-calcineurin pathway, which
promotes dephosphorylation.Rgs9 andRasd2 are involved in
G protein signaling regulating the cAMP pathway (47, 63),
whereas Nrgn is involved in the regulation of the Ca2/
calmodulin pathway (64). In addition, sodium channels and
some of the early response genes, such as Arc, Homer, and
Dusp1, are also regulated by phospho-DARPP-32. A large
fraction of the candidate genes found in the screening are also
involved in intracellular signaling cascades involving G pro-
tein and cation transport. Therefore, thyroid hormone is in-
volved in maintaining an optimal signaling in the striatum
by acting at multiple control points.
In conclusion, we have identified for the first time a set of
genes whose expression is dependent on thyroid hormone in
the adult striatum. We believe that this work opens the way
for more detailed analysis of the effects of thyroid hormone
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FIG. 4. Role of thyroid hormone in the control of signaling in the
striatum. Shown is a simplified scheme of signaling pathways in the
striatum. DARPP-32 phosphorylation is under control of the cAMP
pathway, which promotes phosphorylation, and by the Ca2-calmod-
ulin (CaM) pathway, which promotes dephosphorylation. cAMP pro-
duction is under control of G protein-coupled membrane receptors
such as dopamine receptors (D1, D2) and others not included in the
figure, such as opiate receptors, adenosine, and serotonin receptors.
Voltage-dependent Ca2 channels (VDCC), N-methyl-D-aspartate
(NMDA) glutamate receptors, dopamine 2 receptors (D2), andGABAA
receptors (not shown) regulate intracellular Ca2 concentration and
CaM activation. Genes regulated by thyroid hormone are involved in
different control points of the signaling cascade, as shown by the
arabic numerals: 1, G protein-coupled receptors; 2, Ca2 signaling
and CaM activation; 3, MAPK pathways; 4, early gene transcription;
5, ion channels. PLC, Phospholipase C; PKA, protein kinase A; PP-2B,
calcium and calmodulin-dependent protein phosphatase, or cal-
cineurin; CaMKIV, calcium and calmodulin-dependent kinase IV;
PP-1, protein phosphatase 1.
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in the adult brain and their beneficial therapeutic effects in
affective disorders.
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